Objective: To determine the evolution, associated factors and the outcomes of transplanted people one year after the evolution of a cohort in Mexico.
Method: Kidney transplant cohort from 2013 to 2017 in Mexico. 1118 patients were analyzed.
Background: General anesthesia is the conventional management of renal transplant, and its evolution has revolved around the development of new drugs; however, a group of patients meet conditions for neuraxial anesthesia, because of their comorbidities, who are at greater risk of complications with general anesthesia and are not favorable to grafting.
Methods: We conducted a controlled clinical trial of 109 renal transplant recipients where renal function was evaluated at 24, 48, and 72 hours and 3 months after transplant, and we compared regional, general anesthesia with inhaled anesthetic and total intravenous anesthesia. It was performed for 1 year, and serum creatinine, urea nitrogen, and electrolytes were evaluated.
Introduction: The assessment of health-related quality of life is essential to renal replacement therapies. We conducted a study to evaluate the change in quality of life at 6 and 12 months after renal transplantation and compared with healthy population and general population.
Methods: A prospective study in 278 renal transplant recipients using the SF-36 survey at 0, 6 and 12 months after transplantation.